ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activationWEISSMÜLLER, Sabrina; SEMMLER, Linda Y; KALINKE, Ulrich et al.Blood. 2012, Vol 119, Num 26, pp 6268-6277, issn 0006-4971, 10 p.Article

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinomaSTROME, Scott E; HAIDONG DONG; KASPERBAUER, Jan L et al.Cancer research (Baltimore). 2003, Vol 63, Num 19, pp 6501-6505, issn 0008-5472, 5 p.Article

Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory moleculesKUDO-SAITO, Chie; SCHLOM, Jeffrey; HODGE, James W et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 1090-1099, issn 1078-0432, 10 p.Article

CD28 Negative T Cells: Is Their Loss Our Gain?MOU, D; ESPINOSA, J; LO, D. J et al.American journal of transplantation (Print). 2014, Vol 14, Num 11, pp 2460-2466, issn 1600-6135, 7 p.Article

B7-H1 Overexpression Regulates Epithelial―Mesenchymal Transition and Accelerates Carcinogenesis in SkinYUJIA CAO; LU ZHANG; KAMIMURA, Yosuke et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 4, pp 1235-1243, issn 0008-5472, 9 p.Article

CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in TumorQUNRUI YE; SONG, De-Gang; POUSSIN, Mathilde et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 44-55, issn 1078-0432, 12 p.Article

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies : Immunologic checkpoints for cancer treatment: from scientific rationale to clinical applicationASCIERTO, Paolo A; SIMEONE, Ester; SZNOL, Mario et al.Seminars in oncology. 2010, Vol 37, Num 5, pp 508-516, issn 0093-7754, 9 p.Article

Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysisWINTTERLE, Sabine; SCHREINER, Betting; MITSDOERFFER, Meike et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7462-7467, issn 0008-5472, 6 p.Article

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effectCHOI, K.-J; KIM, J.-H; LEE, Y.-S et al.Gene therapy (Basingstoke). 2006, Vol 13, Num 13, pp 1010-1020, issn 0969-7128, 11 p.Article

The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 TherapyTIHUI FU; QIUMING HE; SHARMA, Padmanee et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 16, pp 5445-5454, issn 0008-5472, 10 p.Article

The costimulatory role of TIM moleculesRODRIGUEZ-MANZANET, Roselynn; DEKRUYFF, Rosemarie; KUCHROO, Vijay K et al.Immunological reviews. 2009, Vol 229, pp 259-270, issn 0105-2896, 12 p.Article

Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activityVERMEIREN, J; CEUPPENS, J. L; HAEGEL-KRONENBERGER, H et al.Clinical and experimental immunology (Print). 2004, Vol 135, Num 2, pp 253-258, issn 0009-9104, 6 p.Article

Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cellsCHONGYUN FANG; MIWA, Takashi; SONG, Wen-Chao et al.Blood. 2011, Vol 118, Num 4, pp 1008-1014, issn 0006-4971, 7 p.Article

Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412RÖMER, Paula S; BERR, Susanne; AVOTA, Elita et al.Blood. 2011, Vol 118, Num 26, pp 6772-6782, issn 0006-4971, 11 p.Article

B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerancePARK, Jang-June; OMIYA, Ryusuke; YINGJIA LIU et al.Blood. 2010, Vol 116, Num 8, pp 1291-1298, issn 0006-4971, 8 p.Article

TOM1L Is Involved in a Novel Signaling Pathway Important for the IL-2 Production in Jurkat T Cells Stimulated by CD3/CD28 CoLigationELMARGHANI, Ahmed; ABUABAID, Hanan; KJELLEN, Peter et al.Mediators of inflammation. 2009, Vol 2009, Num 2, issn 0962-9351, 416298.1-416298.9Article

Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumorsKAUFMAN, Howard L; COHEN, Seth; CHEUNG, Ken et al.Human gene therapy. 2006, Vol 17, Num 2, pp 239-244, issn 1043-0342, 6 p.Article

CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the DesertYUWEN ZHU; LIEPING CHEN.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 3-5, issn 1078-0432, 3 p.Article

Were monocytes responsible for initiating the cytokine storm in the TGN1412 clinical trial tragedy?SANDILANDS, G. P; WILSON, M; HUSER, C et al.Clinical and experimental immunology (Print). 2010, Vol 162, Num 3, pp 516-527, issn 0009-9104, 12 p.Article

CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote toleranceKURTZ, Josef; RAVAL, Forum; VALLOT, Casey et al.Blood. 2009, Vol 113, Num 15, pp 3475-3484, issn 0006-4971, 10 p.Article

FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft ModelRAYCHAUDHURI, Siba P; KUNDU-RAYCHAUDHURI, Smriti; TAMURA, Kouichi et al.Journal of investigative dermatology. 2008, Vol 128, Num 8, pp 1969-1976, issn 0022-202X, 8 p.Article

Mouse B7-H3 induces antitumor immunitySUN, X; VALE, M; LEUNG, E et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 20, pp 1728-1734, issn 0969-7128, 7 p.Article

Urinary CD80 Excretion Increases in Idiopathic Minimal-Change DiseaseGARIN, Eduardo H; DIAZ, Leila N; WEI MU et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 2, pp 260-266, issn 1046-6673, 7 p.Article

Costimulation Blockade of CD40 and CD28 Pathways in Limb TransplantationTUNG, T. H. H; MACKINNON, S. E; MOHANAKUMAR, T et al.Transplantation proceedings. 2008, Vol 40, Num 10, pp 3723-3724, issn 0041-1345, 2 p.Article

Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cellsYONGWEN CHEN; CHENGYING YANG; NAISHI JIN et al.International immunopharmacology. 2007, Vol 7, Num 8, pp 1102-1110, issn 1567-5769, 9 p.Article